Agenus Inc. 13D and 13G filings for MiNK Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-05-26 5:03 pm Purchase | 2023-05-19 | 13D | MiNK Therapeutics, Inc. INKT | AGENUS INC AGEN | 21,522,157 62.500% | 177,472 (+0.83%) | Filing |
| 2023-05-03 5:23 pm Sale | 2023-05-01 | 13D | MiNK Therapeutics, Inc. INKT | AGENUS INC AGEN | 21,344,685 62.000% | -4,988,273 (-18.94%) | Filing |
| 2021-10-28 4:30 pm Purchase | 2021-10-19 | 13D | MiNK Therapeutics, Inc. INKT | AGENUS INC AGEN | 26,332,958 79.800% | 26,332,958 (New Position) | Filing |